Lv52
1306 积分 2024-08-18 加入
Metabolism, Excretion, and Pharmacokinetics of Lorlatinib (PF‐06463922) and Evaluation of the Impact of Radiolabel Position and Other Factors on Comparability of Data Across 2 ADME Studies
6小时前
待确认
Interaction of bile salts with gastrointestinal mucins
8小时前
待确认
Kinase Inhibitors FDA-Approved 2018-2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities
8小时前
待确认
The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole, Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS
23小时前
待确认
Based on the CROWN Findings, Lorlatinib Should Be the Preferred First-Line Treatment for Patients With Advanced ALK-Positive NSCLC
1个月前
已完结
An associative memory Hamiltonian model for DNA and nucleosomes
1个月前
已关闭
Triglyceride Metabolism in the Liver
1个月前
已完结
Lipids as mediators of cancer progression and metastasis
1个月前
已完结
Microcystin-LR induces fatty liver metabolic disease in zebrafish through the PPARα-NOD1 pathway: In vivo, in vitro, and in silico investigations
3个月前
已完结
Prediction of pharmacokinetics of an anaplastic lymphoma kinase inhibitor in rat and monkey: application of physiologically based pharmacokinetic model as an alternative tool to minimise animal studies
4个月前
已完结
皖公网安备34019202002308
